Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run Zhuang

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Biochemistry|March 6, 2002
cis-Retinol/androgen dehydrogenase, isozyme 3 (CRAD3): a short-chain dehydrogenase active in a reconstituted path of 9-cis-retinoic acid biosynthesis in intact cellsRun Zhuang, Min Lin, Joseph L Napoli
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCoco Kusiak, Jonathan R Walsh, Run Zhuang
Plos One|January 27, 2017
Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic ProfileZhengjia Chen, Zheng Li, Run Zhuang, et al.
Psychological Trauma : Theory, Research, Practice and Policy|July 6, 2023
Psychiatric service dog placements are associated with better daily psychosocial functioning for military veterans with posttraumatic stress disorderSarah C Leighton, Kerri E Rodriguez, Run Zhuang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 24, 2025
Using AI-generated digital twins to boost clinical trial efficiency in Alzheimer's diseaseDeli Wang, Hana Florian, Shau-Yu Lynch, et al.
Scientific Reports|January 18, 2024
The cortisol awakening response in a 3 month clinical trial of service dogs for veterans with posttraumatic stress disorderLeanne O Nieforth, Kerri E Rodriguez, Run Zhuang, et al.
Biometrical Journal. Biometrische Zeitschrift|September 22, 2023
CITIES: Clinical trials with intercurrent events simulatorAhmad Hakeem Abdul Wahab, Yongming Qu, Hege Michiels, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman PrimatesSean P Brown, Paul Dransfield, Marc Vimolratana, et al.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full AgonistSean P Brown, Paul J Dransfield, Marc Vimolratana, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biochemistry|March 6, 2002
cis-Retinol/androgen dehydrogenase, isozyme 3 (CRAD3): a short-chain dehydrogenase active in a reconstituted path of 9-cis-retinoic acid biosynthesis in intact cellsRun Zhuang, Min Lin, Joseph L Napoli
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCoco Kusiak, Jonathan R Walsh, Run Zhuang
Plos One|January 27, 2017
Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic ProfileZhengjia Chen, Zheng Li, Run Zhuang, et al.
Psychological Trauma : Theory, Research, Practice and Policy|July 6, 2023
Psychiatric service dog placements are associated with better daily psychosocial functioning for military veterans with posttraumatic stress disorderSarah C Leighton, Kerri E Rodriguez, Run Zhuang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 24, 2025
Using AI-generated digital twins to boost clinical trial efficiency in Alzheimer's diseaseDeli Wang, Hana Florian, Shau-Yu Lynch, et al.
Scientific Reports|January 18, 2024
The cortisol awakening response in a 3 month clinical trial of service dogs for veterans with posttraumatic stress disorderLeanne O Nieforth, Kerri E Rodriguez, Run Zhuang, et al.
Biometrical Journal. Biometrische Zeitschrift|September 22, 2023
CITIES: Clinical trials with intercurrent events simulatorAhmad Hakeem Abdul Wahab, Yongming Qu, Hege Michiels, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman PrimatesSean P Brown, Paul Dransfield, Marc Vimolratana, et al.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full AgonistSean P Brown, Paul J Dransfield, Marc Vimolratana, et al.
Pageof 2